Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subetta in Type I Diabetes Mellitus
NCT01868594Phase 4Completed
- Sponsor
- Materia Medica Holding
- Start
- May 2013
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing Subetta Group with Placebo Group (2 arms). Primary endpoint: Changes in the Mean Value of HbA1c at 36 weeks. Started May 2013; status: completed.
02
Drugs
Subetta
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01868594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01868594.